Literature DB >> 10588221

Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.

H Swan1, K Piippo, M Viitasalo, P Heikkilä, T Paavonen, K Kainulainen, J Kere, P Keto, K Kontula, L Toivonen.   

Abstract

OBJECTIVES: The purpose of this study was to provide clinical and anatomical characteristics as well as genetic background of a malignant arrhythmogenic disorder.
BACKGROUND: An inherited autosomally dominant cardiac syndrome causing stress-induced polymorphic ventricular tachycardia and syncope in the absence of structural myocardial changes was detected in two families.
METHODS: Two unrelated families with six victims of sudden death and 51 living members were evaluated. Resting and exercise electrocardiograms (ECG), echocardiography, magnetic resonance imaging (MRI), cineangiography, microscopic examination of endomyocardial biopsies and a drug testing with a class IC antiarrhythmic agent flecainide were performed. A genetic linkage analysis was carried out to map the gene locus.
RESULTS: Of the 24 affected individuals, 10 had succumbed with six cases of sudden death, and 14 survivors showed evidence of disease. Exercise stress test induced ventricular bigeminy or polymorphic ventricular tachycardia in affected individuals. Three children initially examined before 10 years of age developed arrhythmias during a four-year follow-up. Resting ECGs were normal in affected subjects except a slight prolongation of the QT intervals adjusted for heart rate (QTc) (430 +/- 18 vs. 409 +/- 19 ms, affected vs. nonaffected, p < 0.01). Administration of flecainide did not induce ECG abnormalities encountered in familial idiopathic ventricular fibrillation. Ventricular volumes, contractility and wall measurements were normal by echocardiography, right ventricular cineangiography and MRI. Histopathological examination showed no fibrosis or fatty infiltration. The cumulative cardiac mortality by the age of 30 years was 31%. The disease locus was assigned to chromosome 1q42-q43, with a maximal pairwise lod score of 4.74 in the two families combined. Only one heterozygous carrier was clinically unaffected suggesting high disease penetrance in adulthood.
CONCLUSIONS: A distinct cardiac disorder linked to chromosome 1q42-q43 causes exercise-induced polymorphic ventricular tachycardia in structurally normal hearts and is highly malignant. Delayed clinical manifestation necessitates repeated exercise electrocardiography to assure diagnosis in young individuals of the families.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588221     DOI: 10.1016/s0735-1097(99)00461-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  73 in total

Review 1.  The molecular basis of cardiac arrhythmias.

Authors:  Kalyanam Shivkumar; Narayana S Murali; Subramaniam C Krishnan
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 2.  Genetic basis for the origin of cardiac arrhythmias: implications for therapy.

Authors:  Mackenzi Mbai; Sridharan Rajamani; Brian P Delisle; Blake D Anson; Corey Anderson; Jonathan C Makielski; Craig T January
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 3.  Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels.

Authors:  Silvia G Priori; Carlo Napolitano
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Modulation of transmural repolarization.

Authors:  Charles Antzelevitch
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

5.  Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy.

Authors:  Wendy Creighton; Renu Virmani; Robert Kutys; Allen Burke
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 6.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

7.  Inefficacious ICD shocks treated with left cardiac sympathetic denervation in a patient with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Antonio Sorgente; Carlo de Asmundis; Fatih Bayrak; Gian-Battista Chierchia; Andrea Sarkozy; Marc Noppen; Pedro Brugada
Journal:  J Cardiol Cases       Date:  2011-06-15

8.  Circadian Variation of Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Christina Y Miyake; S Yukiko Asaki; Gregory Webster; Richard J Czosek; Joseph Atallah; Kishor Avasarala; Sri O Rao; Patricia E Thomas; Jeffrey J Kim; Santiago O Valdes; Caridad de la Uz; Yunfei Wang; Xander H T Wehrens; Dominic Abrams
Journal:  JACC Clin Electrophysiol       Date:  2017-08-30

Review 9.  Cardiac repolarization. The long and short of it.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2005-09       Impact factor: 5.214

10.  A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.

Authors:  Junko Arakawa; Akira Hamabe; Takeshi Aiba; Tomoo Nagai; Mikoto Yoshida; Takumi Touya; Norio Ishigami; Hideki Hisadome; Shuichi Katsushika; Hirotsugu Tabata; Yoshihiro Miyamoto; Wataru Shimizu
Journal:  Heart Vessels       Date:  2014-08-05       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.